 | • レポートコード：MRC2303M127 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：ヘルスケア |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| モルドールインテリジェンス社の本調査資料によると、世界の酸化ストレスアッセイ市場規模が、予測期間中（2022年〜2027年）に年平均成長率9%で拡大すると予測されています。本書は、酸化ストレスアッセイの世界市場にフォーカスし、最新動向と今後の市場性などをまとめており、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（機器、消耗品、サービス）分析、検査種類別（間接アッセイ、抗酸化能アッセイ、酵素ベースアッセイ、活性酸素種ベースアッセイ）分析、技術別（酵素免疫測定法、フローサイトメトリー、クロマトグラフィー、顕微鏡検査、その他）分析、疾患別（心血管疾患、慢性閉塞性肺疾患、がん）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などが掲載されています。また、Abcam PLC、AMSBIO、Biovision Inc、Cell Biolabs, Inc、Enzo life sciences, Inc、Merck KGaA、ImmunoChemistry Technologies、Promega Corporation、Qiagen、Thermo fisher scientificなど、主要企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の酸化ストレスアッセイ市場規模：製品別 - 機器の市場規模 - 消耗品の市場規模 - サービスの市場規模 ・世界の酸化ストレスアッセイ市場規模：検査種類別 - 間接アッセイの市場規模 - 抗酸化能アッセイの市場規模 - 酵素ベースアッセイの市場規模 - 活性酸素種ベースアッセイの市場規模 ・世界の酸化ストレスアッセイ市場規模：技術別 - 酵素免疫測定法における市場規模 - フローサイトメトリーにおける市場規模 - クロマトグラフィーにおける市場規模 - 顕微鏡検査における市場規模 - その他における市場規模 ・世界の酸化ストレスアッセイ市場規模：疾患別 - 心血管疾患の市場規模 - 慢性閉塞性肺疾患の市場規模 - がんの市場規模 ・世界の酸化ストレスアッセイ市場規模：地域別 - 北米の酸化ストレスアッセイ市場規模 アメリカの酸化ストレスアッセイ市場規模 カナダの酸化ストレスアッセイ市場規模 メキシコの酸化ストレスアッセイ市場規模 … - ヨーロッパの酸化ストレスアッセイ市場規模 イギリスの酸化ストレスアッセイ市場規模 フランスの酸化ストレスアッセイ市場規模 ドイツの酸化ストレスアッセイ市場規模 … - アジア太平洋の酸化ストレスアッセイ市場規模 中国の酸化ストレスアッセイ市場規模 インドの酸化ストレスアッセイ市場規模 日本の酸化ストレスアッセイ市場規模 … - 南米/中東の酸化ストレスアッセイ市場規模 ブラジルの酸化ストレスアッセイ市場規模 アルゼンチンの酸化ストレスアッセイ市場規模 南アフリカの酸化ストレスアッセイ市場規模 … - その他地域の酸化ストレスアッセイ市場規模 ・競争状況 ・市場機会・将来の動向 |
The Oxidative Stress Assay Market is projected to register a CAGR of 9% during the forecast period (2022-2027).
Amidst COVID-19, the oxidative stress assay market is expected to grow due to the increasing investment in research and development activities across the globe. According to the article titled “Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants” published in May 2021, oxidative stress and inflammation are intertwined processes that play a vital role in disease progression and response to therapy via interference with multiple signaling pathways. The redox status of a host cell is an important factor in viral entry due to the unique conditions required for the conformational changes that ensure the binding and entry of a virus into the host cell. Such studies demonstrate how oxidative stress assays can be useful in finding COVID-19 progression and may propel the growth of the market over the coming years.
The rapid growth in the biopharmaceutical and biotechnology industries and the increase in chronic disorders are among the major factors expected to drive the growth of the oxidative stress assay market. According to the Center for Disease Control and Prevention (CDC) May 2022 update, six in ten adults in the United States have a chronic disease, and four in ten adults have two or more. Such a high prevalence of chronic diseases increased the demand for oxidative stress assays owing to the increased efficacy and precision of the results as chronic disorders result in an imbalance in oxidant and antioxidant levels.
Additionally, the increasing research studies to widen the application of the oxidative stress assay in different diseases is also propelling the growth of the market. For instance, the article titled “Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurposed Drug as an Anticancer Therapy” published in September 2021 reported that as concentrations increased, Reactive Oxygen Species (ROS) paradoxically influenced cancer development, either triggering tumorigenesis or supporting the proliferation of cancer cells at moderate levels of ROS or causing cancer cell death at high levels of ROS. Thus, ROS can be considered an attractive target for the therapy of cancer. It also reported that the use of ROS-based repurposed drugs may be one of the promising ways to overcome current cancer treatment challenges. Such research studies could lead to the development of new products and increasing applications in cancer diagnostics and therapeutics and hence may drive the growth of the market in the near future.
Therefore, due to the aforesaid factors, the market is expected to project growth over the forecast period. However, the high cost of equipment and the lack of trained personnel to handle the equipment may hamper the market’s growth.
Oxidative Stress Assay Market Trends
The Pharmaceutical and Biotechnology Industries Segment is Expected to Hold a Major Market Share in the Oxidative Stress Assay Market.
By end user, the pharmaceutical and biotechnology industries segment is anticipated to garner the largest share of the market. The sudden outbreak of COVID-19 has increased the demand for oxidative stress assays as these products play a major role in the research and development of the pharmaceutical and biotechnology industries. The surge in research and development investments in the pharmaceutical and biotechnology industries is expected to boost the segment’s growth since oxidative stress assays are widely used in the product development process. For instance, the data published by the Organisation for Economic Development and Co-operation (OECD) in 2021 reported that research and development investment intensity in the pharmaceutical and biotechnology sectors in the United States surpassed the 3% milestone, while in China it was 2.1% to 2.2% from the past year. The report also stated that Europe experienced a more modest increase of 2.1 percent in research and development expenditure.
Additionally, the approval of products by the regulatory authorities and the launch of newer products are also contributing to the growth of the segment. For instance, in June 2022, AMSBIO expanded its range of antibodies, biomarkers, and assay kits related to free radicals (ROS and RNS), non-radical reactive derivatives (or oxidants), and antioxidants for researchers investigating the mechanism of oxidative stress.
Considering these factors, the pharmaceutical and biotechnology industry segment is expected to hold the major market share as they employ a significant number of oxidative stress assay products for the R&D of newer disease diagnoses.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
The ever-increasing demand from biopharma and biotechnology companies in this region is expected to drive the growth of the oxidative stress assay market in North America. Moreover, the increase in the adoption of technologically advanced equipment and the presence of more experienced professionals is expected to propel the market growth in this region. Also, the increasing launches of new products by biopharma companies is a contributing factor to the growth of the market as oxidative stress assays play a crucial role in biopharmaceutical production.
Additionally, an upsurge in investment in research and development in the biotechnology sector in the United States is a major contributing factor to the growth of the oxidative stress assay market in this region. For instance, California-based Amgen Inc. invested heavily in its research and development activities and its expenditure for research and development was USD 4.8 billion, USD 4.2 billion, and USD 4.1 billion for 2021, 2020, and 2019, respectively.
Additionally, the strategic initiatives taken by the market players are also propelling the growth of the market. For instance, in July 2021, ImmuchromGmbH signed a partnership agreement with Ilex Life Sciences for North American distribution of gastrointestinal biomarker assays. Immuchrom is a German developer and manufacturer of HPLC applications, photometric assays, and immunoassays, specializing in areas of gastrointestinal disease, the cardiovascular system, oxidative stress, and calcium and bone metabolism. Such initiatives are also boosting the growth of the market.
Thus, considering all these factors, North America is expected to hold a major share in the oxidative stress market.
Oxidative Stress Assay Market Competitor Analysis
The oxidative stress assay market is fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market are Abcam Plc, AMSBIO, Biovision Inc, Cell Biolabs, Inc, Enzo Life Sciences, Inc, Merck KGaA, Immunochemistry Technologies, Promega Corporation, Qiagen, Thermo Fisher Scientific, and others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Defination
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Growth in Biopharmaceutical and Biotechnology Industries
4.2.2 Increasing Investment in the Research and Development
4.3 Market Restraints
4.3.1 High Cost of the Equipment
4.3.2 Lack of Experienced Personnel
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Product
5.1.1 Instruments
5.1.2 Consumables
5.1.3 Services
5.2 By Test Type
5.2.1 Indirect assays
5.2.2 Antioxidant capacity assays
5.2.3 Enzyme based assays
5.2.4 Reactive Oxygen species based assays
5.3 By Technology
5.3.1 Enzyme-linked Immunosorbent Assay (ELISA)
5.3.2 Flow Cytometry
5.3.3 Chromatography
5.3.4 Microscopy
5.3.5 Others
5.4 By Disease Type
5.4.1 Cardiovascular disease
5.4.2 Chronic Obstructive pulmonary disease (COPD)
5.4.3 Cancer
5.5 By End User
5.5.1 Pharmaceutical and Biotechnology Industries
5.5.2 Academic Research institutes
5.5.3 Clinical Research Organizations
5.6 Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 Germany
5.6.2.2 United Kingdom
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Middle East
5.6.4.1 GCC
5.6.4.2 South Africa
5.6.4.3 Rest of Middle East
5.6.5 South America
5.6.5.1 Brazil
5.6.5.2 Argentina
5.6.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abcam PLC
6.1.2 AMSBIO
6.1.3 Biovision Inc
6.1.4 Cell Biolabs, Inc
6.1.5 Enzo life sciences, Inc
6.1.6 Merck KGaA
6.1.7 ImmunoChemistry Technologies
6.1.8 Promega Corporation
6.1.9 Qiagen
6.1.10 Thermo fisher scientific
7 MARKET OPPORTUNITIES AND FUTURE TRENDS